Keratoconjunctivitis Sicca Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Completed
- Keratoconus
- +8 more
- Ocular surface optical coherence tomography
- Needham, MassachusettsBostonSight
2022-03-24
Mar 24, 2022V
Recruiting
- Sjogren's Syndrome
- Keratoconjunctivitis Sicca
- Levocarnitine
- Placebo
- Nashville, TennesseeVanderbilt University Medical Center
2022-01-31
Jan 31, 2022J
Recruiting
- Keratoconjunctivitis Sicca
- +3 more
- Questionnaires
- +2 more
- Baltimore, MarylandWilmer Eye Insitute, Johns Hopkins School of Medicine
2022-01-18
Jan 18, 2022A
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- 0.05% Voclosporin Ophthalmic Solution (VOS)
- +3 more
- Newport Beach, California
- +8 more
2021-12-08
Dec 8, 2021S
Completed
- Keratoconjunctivitis Sicca
- OTX-101 0.09%
- (no location specified)
2021-11-18
Nov 18, 2021S
Completed
- Keratoconjunctivitis Sicca
- cyclosporine
- vehicle of OTX-101
- Rancho Cordova, California
- +2 more
2021-11-18
Nov 18, 2021S
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- OTX-101 0.05%
- +2 more
- Cleveland, Ohio(unnamed)
2021-11-18
Nov 18, 2021M
Completed
- Keratoconjunctivitis Sicca
- Dry Eye
- tavilermide ophthalmic solution
- Placebo
- Phoenix, Arizona
- +21 more
2021-10-18
Oct 18, 2021O
Completed
- Dry Eye
- +2 more
- Intranasal Neurostimulator
- (no location specified)
2021-09-22
Sep 22, 2021S
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- Lifitegrast
- Placebo
- Waterbury, Connecticut
- +12 more
2021-06-02
Jun 2, 2021P
Enrolling by invitation
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- Pro-ocular™ Topical Gel
- Placebo Topical Gel
- Taipei City, TaiwanTri-Service General Hospital, National Defense Medical Center
2021-05-12
May 12, 2021K
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
- Phoenix, Arizona
- +59 more
2021-01-19
Jan 19, 2021K
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121
- Placebo
- Artesia, California
- +10 more
2021-01-04
Jan 4, 2021K
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
- Birmingham, Alabama
- +61 more
2020-12-10
Dec 10, 2020M
Completed
- Keratoconjunctivitis Sicca
- Low Dose 0.155µg/mL SkQ1 ophthalmic solution
- +2 more
- Andover, MassachusettsLawrence General Hospital
2020-10-12
Oct 12, 2020Z
Enrolling by invitation
- Dry Eye
- +4 more
- smile exercise
- 0.1% sodium hyaluronate eye drop
- Guangzhou, Guangdong, ChinaZhonshan Ophthalmic Centre
2020-07-22
Jul 22, 2020C
N
Completed
- Keratoconjunctivitis Sicca
- East Hanover, New JerseyNovartis
2020-05-22
May 22, 2020L
Unknown status
- Uveitis
- +17 more
- No intervention used
- (no location specified)
2020-02-24
Feb 24, 2020B
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Syndrome
- Dexamethasone
- Artificial tear
- Houston, TexasBaylor College of Medicine, Alkek Eye Center
2020-01-22
Jan 22, 2020B
Completed
- Keratoconjunctivitis Sicca
- Lotemax
- +2 more
- Irvine, CaliforniaBausch & Lomb Incorporated
2019-08-28
Aug 28, 2019M
Completed
- Keratoconjunctivitis Sicca
- 1% Tavilermide Ophthalmic Solution
- Placebo Ophthalmic Solution
- Louisville, Kentucky
- +1 more
2019-08-13
Aug 13, 2019M
Completed
- Keratoconjunctivitis Sicca
- 1% Tavilermide Ophthalmic Solution
- Placebo Ophthalmic Solution
- Torrance, CaliforniaMIM-726 Investigational Site
2019-08-13
Aug 13, 2019O
Completed
- Dry Eye Syndromes
- +7 more
- Systane Complete
- Systane Ultra
- Columbus, OhioThe Ohio State University College of Optometry
2019-05-22
May 22, 2019U
Withdrawn
- Ocular Discomfort
- +4 more
- (no location specified)
2019-05-15
May 15, 2019